URGN R&D to Revenue
Urogen Pharma Ltd · R&D to Revenue
URGN R&D to Revenue
Latest reported61.12%period ending
URGN FY R&D/Revenue (0.00% → 61.12%)
Latest values, visible window
High-resolution chart · PNG
URGN r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 61.1242% | |
| 63.2149% | |
| 55.1473% | |
| 82.2071% | |
| 99.1674% | |
| 400.9662% | |
| 273,872.2222% | |
| 3,274.2908% | |
| 229.1861% | |
| 58.6823% | |
| 0% | |
| 0% | |
| 0% |